We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

78 hedge funds and large institutions have $89.7M invested in Forte Biosciences in 2019 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

418% more call options, than puts

Call options by funds: $1.79M | Put options by funds: $346K

138% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 13

29% more capital invested

Capital invested by funds: $69.7M → $89.7M (+$20M)

0% less ownership

Funds ownership: 0.1% → 0.1% (-0%)

6% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 18

3% less funds holding

Funds holding: 80 → 78 (-2)

Holders
78
Holders Change
-2
Holders Change %
-2.5%
% of All Funds
1.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
31
Reduced
13
Closed
18
Calls
$1.79M
Puts
$346K
Net Calls
+$1.45M
Net Calls Change
+$1.33M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.64M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.47M
3
SFM
Sphera Funds Management
Israel
+$1.24M
4
RCMNY
Rubric Capital Management (New York)
New York
+$1.12M
5
Morgan Stanley
Morgan Stanley
New York
+$1.04M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$4.55M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$3.95M
3
FCMI
Foresite Capital Management III
California
-$1M
4
HP
Hound Partners
New York
-$871K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$699K
Name Holding Trade Value Shares
Change 		Change in
Stake
CBT
26
Capital Bank & Trust
California
$544K +$139K +36 +37%
ACA
27
Apis Capital Advisors
New York
$537K -$3.86K -1 -0.8%
Charles Schwab
28
Charles Schwab
California
$513K +$88.9K +23 +22%
Victory Capital Management
29
Victory Capital Management
Texas
$479K -$7.73K -2 -2%
BF
30
Blankinship & Foster
California
$437K – – –
GIM
31
Granahan Investment Management
Massachusetts
$431K -$19.3K -5 -5%
CG
32
Colony Group
Massachusetts
$404K – – –
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$401K +$371K +96 +4,800%
CI
34
CPMG Inc
Texas
$377K -$313K -81 -47%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$368K – – –
Wells Fargo
36
Wells Fargo
California
$364K +$19.3K +5 +6%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$346K +$34.8K +9 +12%
Dimensional Fund Advisors
38
Dimensional Fund Advisors
Texas
$336K – – –
TCIM
39
TIAA CREF Investment Management
New York
$330K -$174K -45 -36%
PCM
40
Prelude Capital Management
New York
$327K +$309K +80 New
Renaissance Technologies
41
Renaissance Technologies
New York
$302K +$286K +74 New
BP
42
BBR Partners
New York
$299K – – –
Stifel Financial
43
Stifel Financial
Missouri
$297K +$11.6K +3 +4%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$277K +$23.2K +6 +10%
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$262K +$58K +15 +31%
HLA
46
Hamilton Lane Advisors
Pennsylvania
$217K – – –
AG
47
Algert Global
California
$213K +$201K +52 New
JMPWA
48
JP Morgan Private Wealth Advisors
California
$197K – – –
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$187K – – –
Simplex Trading
50
Simplex Trading
Illinois
$187K +$135K +35 +318%
1
2
3 4

FBRX Hedge Fund Activity: Q1 2019 in Review

78 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2019, worth a combined $89.7M — up 29% from $69.7M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of FBRX and 17 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 31 added.

The largest buyer was BlackRock, adding an estimated $1.64M. The largest seller was Citigroup, cutting an estimated $4.55M.

  • 78 institutional investors held Forte Biosciences (FBRX) as of Q1 2019, down from 80 in Q4 2018.
  • Funds reported $89.7M of Forte Biosciences stock for Q1 2019, up 29% quarter-over-quarter.
  • 17 funds opened new Forte Biosciences positions in Q1 2019 and 18 closed out, a net change of -1 holder.
  • The largest Forte Biosciences buyer in Q1 2019 was BlackRock, an estimated $1.64M added.
  • The largest Forte Biosciences seller in Q1 2019 was Citigroup, an estimated $4.55M sold.

Based on aggregated 13F filings for Q1 2019.